Advanced Treatment Options Fuel Growth of Global Postpartum Hemorrhage (PPH) Treatment Devices Market
The global postpartum hemorrhage (PPH) treatment devices market is set to enjoy a valuation of US$ 777 million in 2022 and further expand at a CAGR of 4% to reach US$ 909 million by the end of 2026. The Postpartum Hemorrhage (PPH) Treatment Devices Market refers to the medical devices used to control and treat excessive bleeding that occurs after childbirth. The market includes a variety of devices such as uterine balloons, compression devices, and hemostatic agents.
The increasing prevalence of postpartum hemorrhage and the rising awareness regarding the availability of advanced treatment options are some of the factors driving the growth of this market. Additionally, the technological advancements in PPH treatment devices and the increasing adoption of minimally invasive procedures are also contributing to the market growth
Download Free Sample Copy of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=7644
Overall, the PPH treatment devices market is expected to continue to grow as the prevalence of postpartum hemorrhage remains high, and healthcare providers continue to adopt new and advanced treatment options
Key Takeaways from Market Study
- The increasing prevalence of postpartum hemorrhage and the rising awareness regarding the availability of advanced treatment options are driving the growth of this market.
- North America held the largest market share in 2020, followed by Europe and the Asia Pacific.
- Uterine balloons, compression devices, and hemostatic agents are some of the key devices used in the PPH treatment market.
- The market is characterized by the presence of key players such as Becton, Dickinson and Company, Cook Medical Inc., Teleflex Incorporated, C. R. Bard, Inc., and Utah Medical Products, Inc.
- Technological advancements in PPH treatment devices and the increasing adoption of minimally invasive procedures are expected to drive market growth in the coming years.
- The market is expected to continue to grow as healthcare providers adopt new and advanced treatment options to effectively manage postpartum hemorrhage
Competitive Landscape
Leading firms in the postpartum haemorrhage devices market place a strong emphasis on activities for organic growth, such as the introduction of new systems, the approval of products, patents, and marketing through events.
Partnerships, acquisitions, and collaborations are a few examples of market-based inorganic growth strategies. Participants in the market have been able to expand their customer bases and business operations across areas thanks to these activities.
- On August 9, 2022, BD (Becton, Dickinson and Company), a top global medical technology company, and Labcorp, a renowned life sciences company, announced a collaboration agreement. This framework will be used to develop, produce, market, and sell flow cytometry-based companion diagnostics (CDx).
Get Customization on this Report for Specific Research Solutions – https://www.factmr.com/connectus/sample?flag=RC&rep_id=7644
Key Companies Profiled
- 3RD Stone Design, Inc.
- Bactiguard AB
- Becton, Dickinson, and Company
- C. R. Bard, Inc.
- Cook Medical, Inc.
- Alydia Health
- Revmedx Inc.
- Teleflex Incorporated
- Utah Medical Products, Inc.
Region-Wise Analysis
- North America: North America held the largest market share in 2020, driven by the high prevalence of postpartum hemorrhage in the region, along with the availability of advanced healthcare infrastructure and reimbursement policies. The United States is the largest market in this region.
- Europe: Europe is the second-largest market for PPH treatment devices, driven by the increasing awareness regarding advanced treatment options and favorable government initiatives. The United Kingdom, Germany, and France are some of the key markets in this region.
- Asia Pacific: The Asia Pacific region is expected to witness significant growth in the coming years, driven by the increasing prevalence of postpartum hemorrhage and the rising adoption of advanced treatment options. China, India, and Japan are some of the key markets in this region.
- Latin America: Latin America is also expected to witness significant growth, driven by the increasing healthcare expenditure and government initiatives aimed at improving maternal and child health. Brazil and Mexico are some of the key markets in this region.
- Middle East and Africa: The Middle East and Africa are expected to witness moderate growth, driven by the increasing awareness regarding advanced treatment options and the rising prevalence of postpartum hemorrhage. South Africa, Saudi Arabia, and the UAE are some of the key markets in this region
Segments of Postpartum Hemorrhage Treatment Devices Industry Research
- By Product :
- Uterine Balloon Tamponades
- Non-pneumatic Anti-shock Garments (NASG)
- Uniject Prefilled Injection Systems
- By End User :
- Hospitals
- Clinics
- Others
For in-depth competitive analysis, Buy Now – https://www.factmr.com/checkout/7644
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Xherald
